| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.8 |